Tanaka, Akihito
Sasaki, Sho
Noma, Hisashi
Wang, Jui
Onishi, Yoshihiro
Inaguma, Daijo
Article History
Received: 11 June 2023
Accepted: 20 September 2023
First Online: 25 September 2023
Competing interests
: A. Tanaka has received lecture fee from Kissei Pharmaceutical Co., Ltd. D. Inaguma has received lecture fee from Kyowa Kirin Co., Ltd., Torii Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., and Ono Pharmaceutical Co., Ltd. H. Noma reports personal fees from Boehringer Ingelheim, Kyowa Kirin, Toyota Motor Corporation, GlaxoSmithKline, Ono Pharmaceutical, Sony, Kowa Company, Ltd., and Terumo outside the submitted work. All other authors have no competing interests to declare.